Stay updated on Pembrolizumab & Radiation for Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Radiation for Lymphoma Clinical Trial page.

Latest updates to the Pembrolizumab & Radiation for Lymphoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedEnrollment status now indicates recruitment is closed. New navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label updates, along with the revision history change from v3.5.5 to v3.6.0, have been added.SummaryDifference0.4%

- Check18 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, indicating a small update to the page's documentation/versioning.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing the prior Revision: v3.5.3. This indicates a small software version update with no announced changes to content or user-facing features.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a change in the site’s release version rather than any study content.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check97 days agoChange DetectedThe page's revision tag was updated to v3.5.0, and the previous v3.4.3 tag was removed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & Radiation for Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Radiation for Lymphoma Clinical Trial page.